MétaCan
Menu
Back to cohort
Record W2005910933 · doi:10.1158/1535-7163.targ-11-b63

Abstract B63: Targeting cancer cells with a glucose-conjugated DNA repair inhibitor.

2011· article· en· W2005910933 on OpenAlexaff
Karl-Heinz Tomaszowski, Ralf Schirrmacher, Esther Schirrmacher, Bernd Kaina

Bibliographic record

VenueMolecular Cancer Therapeutics · 2011
Typearticle
Languageen
FieldMedicine
TopicGlioma Diagnosis and Treatment
Canadian institutionsMontreal Neurological Institute and Hospital
Fundersnot available
KeywordsTemozolomideCancer researchO-6-methylguanine-DNA methyltransferaseMethyltransferaseDNA repairGuanineDNA damageCancer cellDNALomustineDNA methyltransferaseCancerCisplatinChemistryPharmacologyChemotherapyBiologyBiochemistryVincristineMethylationGliomaNucleotideGenetics

Abstract

fetched live from OpenAlex

Abstract Alkylating agents are important chemotherapeutic drugs used for the treatment of several types of cancers, including brain tumors, melanoma and lymphoma. These chemotherapeutic agents have a strong affinity towards oxygen atoms in DNA giving rise to the important genotoxic DNA lesions O6-methylguanine and O6-chloroethylguanine, which are responsible for the cytotoxic effects of several alkylating anticancer drugs (e.g. temozolomide and lomustine). The DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) is considered as an important player of drug resistance because it removes these DNA adducts from the DNA. The MGMT protein restores guanine in the DNA by a suicide repair reaction leading to irreversible inactivation and degradation of the protein. Therefore depletion of MGMT renders cells more susceptible to treatment with alkylating anticancer drugs. There has been numerous attempts to inactivate MGMT with different inhibitors like O6-benzylguanine (O6-BG) or O6-(4-bromothenyl) guanine (O6-BTG, lomeguatrib) in glioblastoma and malignant melanoma cells. These strategies however have failed thus far, mainly due to the severe side effects associated with the systemic sensitization of the patients to chemotherapeutic agents. The application of targeting strategies for MGMT inhibitors therefore should improve chemotherapy by selective inhibition of MGMT in the tumor. In our previous work we have shown that O6-BG and O6-BTG bound to glucose is efficient in inhibiting MGMT on enzyme level and in the cell, causing sensitization to DNA alkylating N-nitrosoureas (Kaina et. al., 2004; 2010). Here we show, using a quantitative MGMT assay, that intracellular uptake of O6-benzylguanine-C8-glucose (O6-BG-Glu) occurs by a transporter-dependent mechanism and not through passive diffusion. We observed differences in the transport kinetics between several cell lines. Most cancer cell lines are able to take up the inhibitor, whereas normal cells only show marginal uptake of the glucose-conjugated inhibitor. The uptake is probably not depended on the glucose transporter GLUT since blocking of GLUT does not abolishes MGMT inhibition. Uptake of the glucose conjugated inhibitors in cancer cells leads to an increased DNA damage response, induction of apoptosis and significant decrease in surviving fraction after treatment with alkylating anticancer drugs, pointing to the usefulness of the glucose-mediated MGMT inhibitor targeting strategy. References: Kaina et al., J. Pharmacol. Expt. Therap., 311, 585–593 (2004); Kaina et al., Cell. Mol. Life Sci., 67, 3663–3681 (2010) Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2011 Nov 12-16; San Francisco, CA. Philadelphia (PA): AACR; Mol Cancer Ther 2011;10(11 Suppl):Abstract nr B63.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.017
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.028
GPT teacher head0.269
Teacher spread0.241 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2011
Admission routes1
Has abstractyes

Explore more

Same venueMolecular Cancer TherapeuticsSame topicGlioma Diagnosis and TreatmentFrench-language works237,207